3-methoxy-5-(methoxycarbonyl)benzoic acid, 95.0%, 1g

Danofloxacin, 95.0%, 25mg

2,2'-(2,5-Dimethoxy-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 10g

tert-Butyl 1-bromo-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate, 95%, 250mg

ethyl 3-{[2-(pyrrolidin-1-yl)ethyl]amino}propanoate, 95.0%, 10g

3-(Oxetan-3-yloxy)azetidine, 85%, 50mg

2,4-Bis(trifluoromethyl)bromobenzene, 98.0%, 100g

Ethyl 3-(2-ethoxy-2-oxoethoxy)isonicotinate, 95.0%, 250mg

28-(tert-butoxy)-1-(diazyn-1-ium-1-yl)-28-oxo-4,7,10,13,16,19,22,25-octaoxa-1-azaoctacosan-1-ide, 95%, 250mg

(1S)-1-(5-Chloropyridin-2-yl)ethan-1-amine dihydrochloride, 97%, 1g

[1-(3-ethyl-1,2,4-oxadiazol-5-yl)ethyl]amine trifluoroacetate, 95.0%, 1g

3-(3-Methylphenyl)benzoic acid, 97.0%, 25g

Unendlich korrigiertes Plan-PL-M 20x/0,40 IOS-Objektiv. Arbeitsabstand 7,8 mm. Keine Deckglaskorrektur